Senior Medical Writer, Cell and Gene Therapy

Interested in Senior Medical Writer, Cell and Gene Therapy jobs in the Netherlands? You're in the right place.

Medical affairs hiring is expanding fast in 2026 as biotech companies mature toward commercialisation, with the strongest demand around the Leiden and Amsterdam life-sciences clusters and at the major pharma sites. Employers range from global pharma to scaling Dutch biotechs and specialist medical-communication agencies. An advanced clinical or scientific degree, therapeutic-area depth and strong KOL engagement are what push compensation to the top.

To move forward, simply upload your CV to wherewework, and we'll help connect you with real Senior Medical Writer, Cell and Gene Therapy openings from real companies, including the position you're viewing right now.

Here's how it works:
1. Upload your CV once. Click "Apply" in this window. It only takes a moment, and allows us to match your profile with relevant Senior Medical Writer, Cell and Gene Therapy opportunities.
2. We match you with real roles that fit your experience. When companies open Senior Medical Writer, Cell and Gene Therapy positions aligned with your skills, we'll identify the best opportunities for you.
3. You stay fully in control. Before your CV is ever shared, we'll notify you with the exact job title and company name, and ask for your confirmation.
4. Only confirmed applications are sent to employers. Once you approve, the employer receives your application and may contact you directly.

For Senior Medical Writer, Cell and Gene Therapy roles in the Netherlands, salaries typically range from 6,000 EUR to 7,920 EUR gross per month, with an average gross salary of around 6,960 EUR. Regulatory or scientific writing skill, therapeutic knowledge and command of submission standards raise earnings.

While you're here, explore wherewework to discover what it's really like to work at the Netherlands' top healthcare and pharmaceuticals companies, through interview experiences, employee reviews, and community feedback.